MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025)

MeiraGTx Holdings' (MGTX) quarterly Net Equity Issued and Repurchased came in at $5.2 million in Q4 2025, up 21.25% YoY from $4.3 million in Q4 2024, and down 5.04% on a QoQ basis from $5.4 million in Q2 2025.

Analysis

MeiraGTx Holdings (MGTX) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends

MeiraGTx Holdings (MGTX) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $5.2 million in Q4 2025.

  • Quarterly Net Equity Issued and Repurchased rose 21.25% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $15.1 million (down 74.62% YoY) and the FY2025 annual result came in at $15.1 million, down 74.62% from the prior year.
  • Net Equity Issued and Repurchased retreated to $5.2 million in Q4 2025, from $5.4 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $100.0 million in Q4 2023 to a low of -$2.8 million in Q1 2022.
  • A 4-year average of $19.1 million and a median of $4.5 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2024 — Net Equity Issued and Repurchased sank 95.74% — and 2025, when it surged 237.03%.
  • Tracing MGTX's Net Equity Issued and Repurchased over 4 years: stood at -$2.8 million in 2022, then soared by 3704.9% to $100.0 million in 2023, then slumped by 95.74% to $4.3 million in 2024, then advanced by 21.25% to $5.2 million in 2025.
  • The last three Net Equity Issued and Repurchased figures came in at $5.2 million (Q4 2025), $5.4 million (Q2 2025), and $4.5 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.16 Mn
Jun 30, 2025 5.43 Mn
Mar 31, 2025 4.48 Mn
Dec 31, 2024 4.26 Mn
Sep 30, 2024 51.94 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 1.59 Mn
Dec 31, 2023 100.00 Mn
Mar 31, 2022 -2.77 Mn
Dec 31, 2020 9.60 Mn
Sep 30, 2019 75.20 Mn
Mar 31, 2019 80.00 Mn
Jun 30, 2018 25.90 Mn
Mar 31, 2018 43.85 Mn
Dec 31, 2017 9.12 Mn
Sep 30, 2017 7.53 Mn